Page 186 - Mercy MOR All Regions_FinalwithVideo

Tiffin Hospital
Key Performance Indicators Metric 201 173 (94) % Variance 16.2% 180
Actual
Variance
Prior
Budget
$701,106
($47,209)
Supply Expense
$782,465
$735,256
-6.4%
$6,028,749
2.5%
$6,181,009
Net Patient Revenue
$152,260
$5,841,377
0.5%
12.2%
12.0%
Supply Expense % Net Patient Revenue
12.7%
4.1%
Supply Expense per EIPA
-20.0%
$888
($178)
$873
$1,066
28
Total Admissions
Total Patient Days
536
9.8%
593
540

53
803
828
-11.4%
734
Total EIPAs

27
IP Surgeries
21
28.6%
6
25

OP Surgeries
303

366
-13.1%
Total Surgeries
318
(48)
-65.4%
26
(17)
Outpatient Cath Lab Procedures 291 345 (54) -15.7% 278
9
22

Site Performance Summary
Tiffin's supply expense for January was unfavorable to budget by 6.4% ($48.8K), mostly attributable to continuous growth from Oncology
services on Rx spend, Inpatient Surgery volumes up 28.6% to budget, as well as notable increases in Admissions (16.2%) and Patient
Days (9.8%) corresponding with the influx of flu patients.
Strong Inpatient and Ortho volumes contributed to unfavorable spend in the Implant - Ortho Joint and Implant - Other subaccounts,
respectively.
Lab's supply subaccount was also unfavorable to budget due to doubled spend on Flu Kits from PY (+3.6K) as well as an additional $3K
spend on supplies to kick off a new Hematology Analyzer. Overall, Flu supplies held an increase of $11.6K in spend over PY.
Key Challenges
Tiffin Hospital Leader's Summary
Successfully maintained supply spend below budget despite increased Admissions, Patient Days,
and Inpatient volumes.
Med/Surg
Oncology continues to grow its volumes, including acceptance of transferred patients from
Willard due to maximum capacity reached there.
High-dollar drug spend continues from Oncology services as well (i.e. Keytruda, Avastin, and
Rx
Neulasta).
Inpatient Volumes up 28.6% over PY and Ortho Volumes also saw an increase over PY.
Implants
Additional unfavorable spend attributed to IV's and IV Sets, Laboratory, and Physical
Plant/Maintenance.
Other Expenses
Actions Taken/Planned:
Working to identify and review Pharmacy initiatives for 2018 that could be favorable to Drug
Rx
supply spend.
IV's and IV Sets Initiative set to convert from 3-port IV set to 2-port IV set, effective February 1.
Scheduling meeting with several areas of Leadership to discuss subaccounts impacted by multiple
All
departments to better control areas like Minor Equipment and Instruments.
Administration Meeting with Administration to discuss potential of robotics addition by the end of 2018.